Technology Transfer

Airway Therapeutics, Celonic Group Partner on New COVID-19 Therapeutic

May 21, 2020

The companies have formed a collaboration to develop a novel human recombinant protein as a therapeutic candidate against COVID-19.

Ensuring Smooth Tech Transfer of Bioprocess Operations

April 01, 2020

BioPharm International

Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.

Building Strategic Relationships with CROs

February 15, 2020

BioPharm International

How to adopt win-win strategies and understand quality agreements for complying with cGMP when building strategic relationships with pharmaceutical contract research organizations.

Biologic Drug Manufacturing Capacity on the Agenda for INTERPHEX 2019 Keynote Series

April 03, 2019

Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.

Lonza, Sheba to Collaborate on Automated Cell-Therapy Manufacturing

March 20, 2019

The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies.

PDA to Address Technology Transfers at 2019 Annual Meeting

February 08, 2019

PDA survey and conference discussion will generate information to guidance on technology transfer.

The Impact of Expedited Review Status on Biomanufacturing Facility Design

January 01, 2019

BioPharm International

For rapid scale-up of biomanufacturing under expedited review status, facility design must better integrate product development and manufacturing lifecycle activities.

Boehringer Ingelheim Licenses Global Rights to Cystic Fibrosis Gene Therapy

August 06, 2018

Boehringer Ingelheim joins Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, and Imperial Innovations to form a partnership for developing a new gene therapy to treat cystic fibrosis.

GE and CCRM Partner with DiscGenics on New Cell Therapy

May 30, 2018

GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.

Understanding Validation and Technical Transfer, Part 2

May 01, 2018

BioPharm International

A validation plan developed to support a process unrelated to bio- pharmaceutical manufacture is applied to bio- pharmaceutical processes and systems.